Team:UCL/Science/Bioprocessing
From 2014.igem.org
Joyfaucher (Talk | contribs) |
|||
Line 20: | Line 20: | ||
<img src="https://static.igem.org/mediawiki/2014/6/67/UCLBPHEADER.png" width="100%" height="auto" alt="Sustainable Bioprocessing" /></div> | <img src="https://static.igem.org/mediawiki/2014/6/67/UCLBPHEADER.png" width="100%" height="auto" alt="Sustainable Bioprocessing" /></div> | ||
- | <div class="textArena"> | + | <div class="textArena"><!--- This is the coding for the tabs (ask sanjay before altering this) ---> |
- | <!--- This is the coding for the tabs (ask sanjay before altering this) ---> | + | |
<ul class="tabs"> | <ul class="tabs"> | ||
- | <li><a href="#view1">Basics</a></li> | + | <li class=""><a href="#view1">Basics</a></li> |
- | <li><a href="#view2">Manufacturing</a></li> | + | <li class=""><a href="#view2">Manufacturing</a></li> |
- | <li><a href="#view3">Design</a></li> | + | <li class=""><a href="#view3">Design</a></li> |
- | <li><a href="#view4">Process Options</a></li> | + | <li class=""><a href="#view4">Process Options</a></li> |
- | <li><a href="#view5">Experiments</a></li> | + | <li class=""><a href="#view5">Experiments</a></li> |
- | <li><a href="#view6">Future</a></li> | + | <li class="selected"><a href="#view6">Future</a></li> |
+ | <li class=""><a href="#view7">Industrial Consultation</a></li> | ||
</ul> | </ul> | ||
<div class="tabcontents"> | <div class="tabcontents"> | ||
<!--- This is the first section ---> | <!--- This is the first section ---> | ||
- | <div id="view1"> | + | <div style="display: none;" id="view1"> |
<div class="textTitle"><h4>Bioprocessing?</h4></div> | <div class="textTitle"><h4>Bioprocessing?</h4></div> | ||
Line 47: | Line 47: | ||
<div class="SCJMFHIGHLIGHT"> | <div class="SCJMFHIGHLIGHT"> | ||
<p> | <p> | ||
- | <img src="https://static.igem.org/mediawiki/2014/c/ca/UCLBioprocessEngFigure.png" | + | <img src="https://static.igem.org/mediawiki/2014/c/ca/UCLBioprocessEngFigure.png" style="float:right;margin:0 0 0 10px;" width="50%"> |
The design of a successful bioprocess requires careful analysis of the many factors that impact choice of design parameters and process variables. It is crucial to consider the cost of the process at each stage to assess it's large scale feasibility. For the problem at hand, the following interplay will affect an industry's choice to adopt a novel process: | The design of a successful bioprocess requires careful analysis of the many factors that impact choice of design parameters and process variables. It is crucial to consider the cost of the process at each stage to assess it's large scale feasibility. For the problem at hand, the following interplay will affect an industry's choice to adopt a novel process: | ||
<br><br>(more)</p></div> | <br><br>(more)</p></div> | ||
Line 58: | Line 58: | ||
<div class="slider-wrapper theme-default"><div class="ribbon"></div> | <div class="slider-wrapper theme-default"><div class="ribbon"></div> | ||
<div id="slider" class="nivoSlider"> | <div id="slider" class="nivoSlider"> | ||
- | <img src="https://static.igem.org/mediawiki/2014/4/43/Makeitathome%21.jpg" alt="" | + | <img style="width: 100px; visibility: hidden; display: inline;" src="https://static.igem.org/mediawiki/2014/4/43/Makeitathome%21.jpg" alt=""> |
- | <img src="https://static.igem.org/mediawiki/2014/1/18/UCL_plant_1.jpg" alt="" | + | <img style="width: 100px; visibility: hidden; display: inline;" src="https://static.igem.org/mediawiki/2014/1/18/UCL_plant_1.jpg" alt=""> |
- | <img src="https://static.igem.org/mediawiki/2014/1/16/Processucl.png" alt="" | + | <img style="width: 100px; visibility: hidden; display: inline;" src="https://static.igem.org/mediawiki/2014/1/16/Processucl.png" alt=""> |
- | <img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" alt="" | + | <img style="width: 100px; visibility: hidden; display: inline;" src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" alt=""> |
- | <img src="https://static.igem.org/mediawiki/2014/5/53/B3.PNG" alt="" | + | <img style="width: 100px; visibility: hidden; display: inline;" src="https://static.igem.org/mediawiki/2014/5/53/B3.PNG" alt=""> |
- | <img src="https://static.igem.org/mediawiki/2014/3/38/B5.PNG" alt="" | + | <img style="width: 100px; visibility: hidden; display: inline;" src="https://static.igem.org/mediawiki/2014/3/38/B5.PNG" alt=""> |
- | <img src="https://static.igem.org/mediawiki/2014/b/b0/Plant_2-_UCL.jpg" alt="" | + | <img style="width: 100px; visibility: hidden; display: inline;" src="https://static.igem.org/mediawiki/2014/b/b0/Plant_2-_UCL.jpg" alt=""> |
- | <img src="https://static.igem.org/mediawiki/2014/c/c6/Screen_Shot_2014-10-06_at_12.37.15_PM.png" alt="" | + | <img style="width: 100px; visibility: hidden; display: inline;" src="https://static.igem.org/mediawiki/2014/c/c6/Screen_Shot_2014-10-06_at_12.37.15_PM.png" alt=""> |
- | <img src="https://static.igem.org/mediawiki/2014/b/b0/Microfluidic_3.png" alt="" | + | <img style="width: 100px; visibility: hidden; display: inline;" src="https://static.igem.org/mediawiki/2014/b/b0/Microfluidic_3.png" alt=""> |
- | </div> | + | <img style="display: inline; height: 0px; width: 100px;" src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" class="nivo-main-image"><div class="nivo-caption"></div><div class="nivo-directionNav"><a class="nivo-prevNav">Prev</a><a class="nivo-nextNav">Next</a></div><div style="opacity: 1; left: 0px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="0" rel="0"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-0px;"></div><div style="opacity: 1; left: 13px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="1" rel="0"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-13px;"></div><div style="opacity: 1; left: 26px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="2" rel="0"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-26px;"></div><div style="opacity: 1; left: 39px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="3" rel="0"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-39px;"></div><div style="opacity: 1; left: 52px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="4" rel="0"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-52px;"></div><div style="opacity: 1; left: 65px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="5" rel="0"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-65px;"></div><div style="opacity: 1; left: 78px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="6" rel="0"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-78px;"></div><div style="opacity: 1; left: 91px; top: 0px; width: 9px; height: 0px;" class="nivo-box" name="7" rel="0"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-91px;"></div><div style="opacity: 1; left: 0px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="0" rel="1"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-0px;"></div><div style="opacity: 1; left: 13px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="1" rel="1"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-13px;"></div><div style="opacity: 1; left: 26px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="2" rel="1"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-26px;"></div><div style="opacity: 1; left: 39px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="3" rel="1"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-39px;"></div><div style="opacity: 1; left: 52px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="4" rel="1"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-52px;"></div><div style="opacity: 1; left: 65px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="5" rel="1"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-65px;"></div><div style="opacity: 1; left: 78px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="6" rel="1"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-78px;"></div><div style="opacity: 1; left: 91px; top: 0px; width: 9px; height: 0px;" class="nivo-box" name="7" rel="1"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-91px;"></div><div style="opacity: 1; left: 0px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="0" rel="2"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-0px;"></div><div style="opacity: 1; left: 13px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="1" rel="2"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-13px;"></div><div style="opacity: 1; left: 26px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="2" rel="2"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-26px;"></div><div style="opacity: 1; left: 39px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="3" rel="2"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-39px;"></div><div style="opacity: 1; left: 52px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="4" rel="2"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-52px;"></div><div style="opacity: 1; left: 65px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="5" rel="2"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-65px;"></div><div style="opacity: 1; left: 78px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="6" rel="2"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-78px;"></div><div style="opacity: 1; left: 91px; top: 0px; width: 9px; height: 0px;" class="nivo-box" name="7" rel="2"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-91px;"></div><div style="opacity: 1; left: 0px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="0" rel="3"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-0px;"></div><div style="opacity: 1; left: 13px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="1" rel="3"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-13px;"></div><div style="opacity: 1; left: 26px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="2" rel="3"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-26px;"></div><div style="opacity: 1; left: 39px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="3" rel="3"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-39px;"></div><div style="opacity: 1; left: 52px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="4" rel="3"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-52px;"></div><div style="opacity: 1; left: 65px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="5" rel="3"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-65px;"></div><div style="opacity: 1; left: 78px; top: 0px; width: 13px; height: 0px;" class="nivo-box" name="6" rel="3"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-78px;"></div><div style="opacity: 1; left: 91px; top: 0px; width: 9px; height: 0px;" class="nivo-box" name="7" rel="3"><img src="https://static.igem.org/mediawiki/2014/e/e2/Uclbiopro.PNG" style="position:absolute; width:100px; height:auto; display:block; top:-0px; left:-91px;"></div></div><div class="nivo-controlNav"><a class="nivo-control" rel="0">1</a><a class="nivo-control" rel="1">2</a><a class="nivo-control" rel="2">3</a><a class="nivo-control active" rel="3">4</a><a class="nivo-control" rel="4">5</a><a class="nivo-control" rel="5">6</a><a class="nivo-control" rel="6">7</a><a class="nivo-control" rel="7">8</a><a class="nivo-control" rel="8">9</a></div> |
<div id="htmlcaption" class="nivo-html-caption"> | <div id="htmlcaption" class="nivo-html-caption"> | ||
<strong>This</strong> is an example of a <em>HTML</em> caption with <a href="#">a link</a>. | <strong>This</strong> is an example of a <em>HTML</em> caption with <a href="#">a link</a>. | ||
Line 74: | Line 74: | ||
</div> | </div> | ||
<!---Gallery Slider END---> | <!---Gallery Slider END---> | ||
- | </div | + | </div> |
- | + | <div style="display: none;" id="view2"> | |
- | + | ||
- | <div id="view2"> | + | |
<div class="textTitle"><h4>Overview</h4></div> | <div class="textTitle"><h4>Overview</h4></div> | ||
Line 87: | Line 85: | ||
<div class="SCJMFHIGHLIGHT"> | <div class="SCJMFHIGHLIGHT"> | ||
<p> | <p> | ||
- | <img src="https://static.igem.org/mediawiki/2014/7/72/Current_process.png" | + | <img src="https://static.igem.org/mediawiki/2014/7/72/Current_process.png" style="float:right;margin:0 0 0 10px;" width="50%"> |
<b>Case study sheet 1: treatment strategy for cotton textile mill wastes</b> | <b>Case study sheet 1: treatment strategy for cotton textile mill wastes</b> | ||
<br> | <br> | ||
Line 95: | Line 93: | ||
<br> | <br> | ||
- | <p><h4>Why invest</h4>Text goes here</p> | + | <p></p><h4>Why invest</h4>Text goes here<p></p> |
</div> | </div> | ||
<!--- This is the third section ---> | <!--- This is the third section ---> | ||
- | <div id="view3"> | + | <div style="display: none;" id="view3"> |
<div class="textTitle"><h4>Understanding relevant business perspectives</h4></div> | <div class="textTitle"><h4>Understanding relevant business perspectives</h4></div> | ||
Line 109: | Line 107: | ||
<p>By using <b>whole cell biocatalysis</b> as the workhorse for detoxification, this process will yield lucrative byproducts such as quinones, that can then be separated from the process stream and sold off. | <p>By using <b>whole cell biocatalysis</b> as the workhorse for detoxification, this process will yield lucrative byproducts such as quinones, that can then be separated from the process stream and sold off. | ||
<br> | <br> | ||
- | <p><b>With Immobilization</b> | + | </p><p><b>With Immobilization</b> |
The following outlines the general consensus on the benefits of using the immobilized biocatalyst format, with respect to free-floating systems. | The following outlines the general consensus on the benefits of using the immobilized biocatalyst format, with respect to free-floating systems. | ||
<br>Catalyst Retention – A huge decrease in the losses of valuable catalyst into product streams. These losses are exponential in ‘free biocatalysts’ systems, and economically unfeasible when using costly enzymes. | <br>Catalyst Retention – A huge decrease in the losses of valuable catalyst into product streams. These losses are exponential in ‘free biocatalysts’ systems, and economically unfeasible when using costly enzymes. | ||
- | <li type="square">Minimized Contamination of product streams, eliminating the requirement for subsequent protein deactivation and further downstream processing. This is especially important for containment of our recombinant organisms.</li> | + | </p><li type="square">Minimized Contamination of product streams, eliminating the requirement for subsequent protein deactivation and further downstream processing. This is especially important for containment of our recombinant organisms.</li> |
<li type="square">Flow-rates are not limited by a threshold critical value for “biomass washout”, and only impact substrate-catalyst contact time. Catalyst concentrations can remain steady through independence of the dilution rate (see figure 1.3). High volumetric flow-rates can enhance mass transfer and speed up the removal of inhibitors (e.g. Azo-dye metabolites) from the system.</li> | <li type="square">Flow-rates are not limited by a threshold critical value for “biomass washout”, and only impact substrate-catalyst contact time. Catalyst concentrations can remain steady through independence of the dilution rate (see figure 1.3). High volumetric flow-rates can enhance mass transfer and speed up the removal of inhibitors (e.g. Azo-dye metabolites) from the system.</li> | ||
- | </p> | + | <p></p> |
<br> | <br> | ||
<!---TABLE START---> | <!---TABLE START---> | ||
- | <table style="width:100%"><col width="60%"><col width="40%"><tr><td> | + | <table style="width:100%"><colgroup><col width="60%"><col width="40%"></colgroup><tbody><tr><td> |
<!-- This is the video. Change the align attribute to left to move the video to the left--> | <!-- This is the video. Change the align attribute to left to move the video to the left--> | ||
<div class="video-wrapper"> | <div class="video-wrapper"> | ||
- | <iframe | + | <iframe style="padding:0.5%; border:0.5% #000;" src="//www.youtube.com/embed/0OlMfq5WT6k" allowfullscreen="" align="left" frameborder="0" height="380" width="600"></iframe></div></td><td> |
<!-- This is the video. Change the align attribute to left to move the video to the left--> | <!-- This is the video. Change the align attribute to left to move the video to the left--> | ||
<div class="video-wrapper"> | <div class="video-wrapper"> | ||
- | <iframe | + | <iframe style="padding:0.5%; border:0.5% #000;" src="//www.youtube.com/embed/buf--n4dcUs" allowfullscreen="" align="right" frameborder="0" height="380" width="600"></iframe></div></td></tr></tbody></table> |
<!---TABLE END---> | <!---TABLE END---> | ||
<br><!-- div is a divisor tag that just separates content. This class makes the paragraph in it black--> | <br><!-- div is a divisor tag that just separates content. This class makes the paragraph in it black--> | ||
<div class="SCJMFHIGHLIGHT"> | <div class="SCJMFHIGHLIGHT"> | ||
<p> | <p> | ||
- | <img src="https://static.igem.org/mediawiki/2014/4/49/Microfluidic_set-up_iGEM.JPG" | + | <img src="https://static.igem.org/mediawiki/2014/4/49/Microfluidic_set-up_iGEM.JPG" style="float:right;margin:0 0 0 10px;" width="35%"> |
Paragraph | Paragraph | ||
<br><br>Caption</p></div> | <br><br>Caption</p></div> | ||
Line 135: | Line 133: | ||
</div> | </div> | ||
<!--- This is the fourth section ---> | <!--- This is the fourth section ---> | ||
- | <div id="view4"> | + | <div style="display: none;" id="view4"> |
<div class="textTitle"><h4>Why Microfluidics?</h4></div> | <div class="textTitle"><h4>Why Microfluidics?</h4></div> | ||
Line 141: | Line 139: | ||
<p>Since our project involves designing a novel <a href="https://2014.igem.org/Team:UCL/Science/Bioprocessing">bioprocess</a> using whole-cell biocatalysts, microfluidics presents us with a unique and extremely useful advantage. When it comes to identifying, developing and optimising reactor designs and reaction constraints, this can be performed with ease and with low reagent cost as all variables are scaled down to a micro-level. Most importantly, the scale-down can be carried out without losing any of the accuracy or quantification of data output; this is due the number of sensors and control mechanisms which can be integrated into the microfluidic system.</p><br> | <p>Since our project involves designing a novel <a href="https://2014.igem.org/Team:UCL/Science/Bioprocessing">bioprocess</a> using whole-cell biocatalysts, microfluidics presents us with a unique and extremely useful advantage. When it comes to identifying, developing and optimising reactor designs and reaction constraints, this can be performed with ease and with low reagent cost as all variables are scaled down to a micro-level. Most importantly, the scale-down can be carried out without losing any of the accuracy or quantification of data output; this is due the number of sensors and control mechanisms which can be integrated into the microfluidic system.</p><br> | ||
<!---TABLE START---> | <!---TABLE START---> | ||
- | <table style="width:100%"><col width="60%"><col width="40%"><tr><td> | + | <table style="width:100%"><colgroup><col width="60%"><col width="40%"></colgroup><tbody><tr><td> |
<!-- This is the video. Change the align attribute to left to move the video to the left--> | <!-- This is the video. Change the align attribute to left to move the video to the left--> | ||
<div class="video-wrapper"> | <div class="video-wrapper"> | ||
- | <iframe | + | <iframe style="padding:0.5%; border:0.5% #000;" src="//www.youtube.com/embed/0OlMfq5WT6k" allowfullscreen="" align="left" frameborder="0" height="380" width="600"></iframe></div></td><td> |
<!-- This is the video. Change the align attribute to left to move the video to the left--> | <!-- This is the video. Change the align attribute to left to move the video to the left--> | ||
<div class="video-wrapper"> | <div class="video-wrapper"> | ||
- | <iframe | + | <iframe style="padding:0.5%; border:0.5% #000;" src="//www.youtube.com/embed/buf--n4dcUs" allowfullscreen="" align="right" frameborder="0" height="380" width="600"></iframe></div></td></tr></tbody></table> |
<!---TABLE END---> | <!---TABLE END---> | ||
<br><!-- div is a divisor tag that just separates content. This class makes the paragraph in it black--> | <br><!-- div is a divisor tag that just separates content. This class makes the paragraph in it black--> | ||
<div class="SCJMFHIGHLIGHT"> | <div class="SCJMFHIGHLIGHT"> | ||
<p> | <p> | ||
- | <img src="https://static.igem.org/mediawiki/2014/4/49/Microfluidic_set-up_iGEM.JPG" | + | <img src="https://static.igem.org/mediawiki/2014/4/49/Microfluidic_set-up_iGEM.JPG" style="float:right;margin:0 0 0 10px;" width="35%"> |
The videos above were recorded in the UCL ACBE Microfluidics labs by members of our team. The video on the left is a demonstration of laminar flow across a T-junction microfluidic device. The video on the right demonstrates one of the methods of mixing made possible by microfluidics (herring bone channels etched into the chip). | The videos above were recorded in the UCL ACBE Microfluidics labs by members of our team. The video on the left is a demonstration of laminar flow across a T-junction microfluidic device. The video on the right demonstrates one of the methods of mixing made possible by microfluidics (herring bone channels etched into the chip). | ||
<br><br>The image on the right displays the microfluidics set-up used by our iGEM team. This device and equipment is provided for by the UCL microfluidics lab.</p></div> | <br><br>The image on the right displays the microfluidics set-up used by our iGEM team. This device and equipment is provided for by the UCL microfluidics lab.</p></div> | ||
Line 158: | Line 156: | ||
</div> | </div> | ||
<!--- This is the fifth section ---> | <!--- This is the fifth section ---> | ||
- | <div id="view5"> | + | <div style="display: none;" id="view5"> |
<div class="textTitle"><h4>Why Microfluidics?</h4></div> | <div class="textTitle"><h4>Why Microfluidics?</h4></div> | ||
Line 164: | Line 162: | ||
<p>Since our project involves designing a novel <a href="https://2014.igem.org/Team:UCL/Science/Bioprocessing">bioprocess</a> using whole-cell biocatalysts, microfluidics presents us with a unique and extremely useful advantage. When it comes to identifying, developing and optimising reactor designs and reaction constraints, this can be performed with ease and with low reagent cost as all variables are scaled down to a micro-level. Most importantly, the scale-down can be carried out without losing any of the accuracy or quantification of data output; this is due the number of sensors and control mechanisms which can be integrated into the microfluidic system.</p><br> | <p>Since our project involves designing a novel <a href="https://2014.igem.org/Team:UCL/Science/Bioprocessing">bioprocess</a> using whole-cell biocatalysts, microfluidics presents us with a unique and extremely useful advantage. When it comes to identifying, developing and optimising reactor designs and reaction constraints, this can be performed with ease and with low reagent cost as all variables are scaled down to a micro-level. Most importantly, the scale-down can be carried out without losing any of the accuracy or quantification of data output; this is due the number of sensors and control mechanisms which can be integrated into the microfluidic system.</p><br> | ||
<!---TABLE START---> | <!---TABLE START---> | ||
- | <table style="width:100%"><col width="60%"><col width="40%"><tr><td> | + | <table style="width:100%"><colgroup><col width="60%"><col width="40%"></colgroup><tbody><tr><td> |
<!-- This is the video. Change the align attribute to left to move the video to the left--> | <!-- This is the video. Change the align attribute to left to move the video to the left--> | ||
<div class="video-wrapper"> | <div class="video-wrapper"> | ||
- | <iframe | + | <iframe style="padding:0.5%; border:0.5% #000;" src="//www.youtube.com/embed/0OlMfq5WT6k" allowfullscreen="" align="left" frameborder="0" height="380" width="600"></iframe></div></td><td> |
<!-- This is the video. Change the align attribute to left to move the video to the left--> | <!-- This is the video. Change the align attribute to left to move the video to the left--> | ||
<div class="video-wrapper"> | <div class="video-wrapper"> | ||
- | <iframe | + | <iframe style="padding:0.5%; border:0.5% #000;" src="//www.youtube.com/embed/buf--n4dcUs" allowfullscreen="" align="right" frameborder="0" height="380" width="600"></iframe></div></td></tr></tbody></table> |
<!---TABLE END---> | <!---TABLE END---> | ||
<br><!-- div is a divisor tag that just separates content. This class makes the paragraph in it black--> | <br><!-- div is a divisor tag that just separates content. This class makes the paragraph in it black--> | ||
<div class="SCJMFHIGHLIGHT"> | <div class="SCJMFHIGHLIGHT"> | ||
<p> | <p> | ||
- | <img src="https://static.igem.org/mediawiki/2014/4/49/Microfluidic_set-up_iGEM.JPG" | + | <img src="https://static.igem.org/mediawiki/2014/4/49/Microfluidic_set-up_iGEM.JPG" style="float:right;margin:0 0 0 10px;" width="35%"> |
The videos above were recorded in the UCL ACBE Microfluidics labs by members of our team. The video on the left is a demonstration of laminar flow across a T-junction microfluidic device. The video on the right demonstrates one of the methods of mixing made possible by microfluidics (herring bone channels etched into the chip). | The videos above were recorded in the UCL ACBE Microfluidics labs by members of our team. The video on the left is a demonstration of laminar flow across a T-junction microfluidic device. The video on the right demonstrates one of the methods of mixing made possible by microfluidics (herring bone channels etched into the chip). | ||
<br><br>The image on the right displays the microfluidics set-up used by our iGEM team. This device and equipment is provided for by the UCL microfluidics lab.</p></div> | <br><br>The image on the right displays the microfluidics set-up used by our iGEM team. This device and equipment is provided for by the UCL microfluidics lab.</p></div> | ||
Line 182: | Line 180: | ||
<!--- This is the sixth section ---> | <!--- This is the sixth section ---> | ||
- | <div id="view6"> | + | <div style="display: block;" id="view6"> |
<div class="textTitle"><h4>Our Design Process</h4></div> | <div class="textTitle"><h4>Our Design Process</h4></div> | ||
<!-- This is the main text. Anything in a <p>TEXT</p> is a paragraph and will be spaced appropriately--> | <!-- This is the main text. Anything in a <p>TEXT</p> is a paragraph and will be spaced appropriately--> | ||
<div class="video-wrapper"> | <div class="video-wrapper"> | ||
- | <iframe | + | <iframe style="padding:1%; border:0.5% #000;" src="//www.youtube.com/embed/6UNpqpMS5vA" allowfullscreen="" align="right" frameborder="0" height="380" width="600"></iframe></div> |
<p>We will use rapid polymer prototyping techniques to generate microfluidic chips that will allow us to test our reaction and aid in the construction of a realistic bioprocess, which can be successfully scaled-up for industrial use. As we optimise and change our bioprocess, we can also quickly design new microfluidic chips that can mimic its development on a micro-scale. For example, it is our goal to integrate multiple downstream steps, such as chromatography, in order to isolate potential useful products. Demonstrating this in a microfluidic system is less time-consuming and far more cost effective than doing so at a larger scale.</p><br> | <p>We will use rapid polymer prototyping techniques to generate microfluidic chips that will allow us to test our reaction and aid in the construction of a realistic bioprocess, which can be successfully scaled-up for industrial use. As we optimise and change our bioprocess, we can also quickly design new microfluidic chips that can mimic its development on a micro-scale. For example, it is our goal to integrate multiple downstream steps, such as chromatography, in order to isolate potential useful products. Demonstrating this in a microfluidic system is less time-consuming and far more cost effective than doing so at a larger scale.</p><br> | ||
<p>For our microfluidic bioreactor, we will be using a magnetic free floating bar as our mixing system. This is an effective method of mixing at a microfluidic scale, as demonstrated in the video on the right. This video is of a microfluidic chemostat bioreactor designed by Davies et al. 2014 UCL, using a free-floating bar to mix two dyes.</p><br> | <p>For our microfluidic bioreactor, we will be using a magnetic free floating bar as our mixing system. This is an effective method of mixing at a microfluidic scale, as demonstrated in the video on the right. This video is of a microfluidic chemostat bioreactor designed by Davies et al. 2014 UCL, using a free-floating bar to mix two dyes.</p><br> | ||
<div class="SCJMFHIGHLIGHT"><p> | <div class="SCJMFHIGHLIGHT"><p> | ||
- | <img src="https://static.igem.org/mediawiki/2014/thumb/b/b8/AutoCAD_Device.png/800px-AutoCAD_Device.png" width=32%> | + | <img src="https://static.igem.org/mediawiki/2014/thumb/b/b8/AutoCAD_Device.png/800px-AutoCAD_Device.png" width="32%"> |
- | <img src="https://static.igem.org/mediawiki/2014/thumb/7/71/MicrofluidicsDevice.jpg/800px-MicrofluidicsDevice.jpg" | + | <img src="https://static.igem.org/mediawiki/2014/thumb/7/71/MicrofluidicsDevice.jpg/800px-MicrofluidicsDevice.jpg" style="PADDING-LEFT: 2%" "padding-right:="" 3%"="" width="32%"> |
- | <img src="https://static.igem.org/mediawiki/2014/1/1e/Fluidics_Chip.JPG" | + | <img src="https://static.igem.org/mediawiki/2014/1/1e/Fluidics_Chip.JPG" align="right" width="32%"><br> |
Above are some examples of the microfluidics devices developed by our team for use in the lab at the UCL ACBE. The devices are initially designed using AutoCAD (2D and 3D computer-aided design software), once the designs are finalised they can be 3D-printed using the facilities provided by the UCL Institute of Making and UCL ACBE; allowing our bioprocess and laboratory team to experiment and improve designs.</p></div> | Above are some examples of the microfluidics devices developed by our team for use in the lab at the UCL ACBE. The devices are initially designed using AutoCAD (2D and 3D computer-aided design software), once the designs are finalised they can be 3D-printed using the facilities provided by the UCL Institute of Making and UCL ACBE; allowing our bioprocess and laboratory team to experiment and improve designs.</p></div> | ||
<br> | <br> | ||
Line 201: | Line 199: | ||
</div> | </div> | ||
- | < | + | <!--- This is the seventh section ---> |
+ | <div style="display: block;" id="view7"> | ||
+ | <div class="textTitle"><h3>Industrial Consultation</h3></div> | ||
+ | <!-- This is the main text. Anything in a <p>TEXT</p> is a paragraph and will be spaced appropriately--> | ||
+ | |||
+ | <p>A major part of our project involved engaging with key industrial experts to better understand their wants and needs. We identified the pigment manufacturing and waste water disposal sectors as the two major players who would benefit from our work. By meeting with these leading corporations we have been able to tune our research towards the assenbly of a process that would be most attractive for industry to utilise.</p> | ||
+ | <br> | ||
+ | |||
+ | <h4>Meeting with ETAD - Ecological and Toxicological Association of Dye and Pigment Manufacturers</h4> | ||
+ | <p>ETAD - an association based in Basel represents over 35 different pigment and dyeing corporations internationally, coordinating a group initiative to limit adverse effects on health and the environment by their industry.Present at the meeting were Walter Hoffman – Director of ETAD, Dr Stefan Ehrenberg - Pigment Manufacturing R&D at Bezema, Georg Roentgen – Director of R&D Colours and Textile Effects at Huntsman.</p> | ||
+ | <p>The main reasons for this meeting were: | ||
+ | <li>To encourage industry to consider synthetic biology as a realistic, viable option when looking to reduce the toxicity of their process. | ||
+ | <li>Discuss the major concerns and problem areas the dyeing and pigments industry are currently facing.</p> | ||
+ | <img width="25%" style="float:right;margin:0 0 0 10px;" src="https://static.igem.org/mediawiki/2014/4/41/1924384_10154546138020564_6502621618718289701_n.jpg"></img> | ||
+ | <br> | ||
+ | |||
+ | <h4>Dye Houses vs Dye Synthesis Waste</h4> | ||
+ | |||
+ | <p>The meeting with ETAD raised a number of points for our project. Mr Roentgen questioned how the survival of our bacterial cell would be effected in dyehouse waste as opposed to dye synthesis plant waste. The waste from a dyehouse is a complex mix of azo dyes at approximately 1%-5% concentration in a high salt concentration with the presence of metals copper and chromium. This a harsh environment compared with the waste of a dye synthesis plant, generally containing one or two azo dyes in a simple mixture at 10% concentration.</p> | ||
+ | <br> | ||
+ | <p>This is new information for our project and has greatly influenced us to direct our research towards optimising remediation of dye synthesis waste water. Another advantage of remediation of dye synthesis plant waste water is that the low variety of azo dyes in each batch mixture will make filtration of valuable products a much easier and viable process, enhancing the economic feasibility of our device.</p> | ||
+ | <br> | ||
+ | <h4>Sulphonated Azo Dyes</h4> | ||
+ | <p>The current trend in the textile industry is to reduce the volume of water consumed, leading to a greater use of more soluble dyes. For a dye to be more soluble it must be more polar, as such, many of these soluble dyes have sulfonated groups. The sulphur atom has a electron withdrawing effect making reduction of the azo bond difficult, the industry are finding chemical processes to degrade these dyes to be ineffective. </p> | ||
+ | <p>We feel we can offer an alternative since ..lignin peroxidase…. change this is known to be effective working on azo bonds with sulphur group.</p> | ||
+ | <h4>Conclusions</h4> | ||
+ | <p>Overall the meeting was a great success in guiding our project towards an industrial relevant direction. Running through our presentation highlighted a number of changes needed before the jamboree, specifically putting more emphasis on the novelty and innovation of our project. Ensuring our project delivers a solution that is conscious of the needs of the industry is extremely important to us, meetings such as these are invaluable to the progression of our work.</p> | ||
+ | </div> | ||
</div> | </div> | ||
Revision as of 18:45, 8 October 2014
Our Design Process
We will use rapid polymer prototyping techniques to generate microfluidic chips that will allow us to test our reaction and aid in the construction of a realistic bioprocess, which can be successfully scaled-up for industrial use. As we optimise and change our bioprocess, we can also quickly design new microfluidic chips that can mimic its development on a micro-scale. For example, it is our goal to integrate multiple downstream steps, such as chromatography, in order to isolate potential useful products. Demonstrating this in a microfluidic system is less time-consuming and far more cost effective than doing so at a larger scale.
For our microfluidic bioreactor, we will be using a magnetic free floating bar as our mixing system. This is an effective method of mixing at a microfluidic scale, as demonstrated in the video on the right. This video is of a microfluidic chemostat bioreactor designed by Davies et al. 2014 UCL, using a free-floating bar to mix two dyes.
Above are some examples of the microfluidics devices developed by our team for use in the lab at the UCL ACBE. The devices are initially designed using AutoCAD (2D and 3D computer-aided design software), once the designs are finalised they can be 3D-printed using the facilities provided by the UCL Institute of Making and UCL ACBE; allowing our bioprocess and laboratory team to experiment and improve designs.
An example of one of our microfluidic devices designed on AutoCAD can be downloaded here. This device utilises the basic concept of mixing the cells and dyes, producing a single output stream; much alike to the bioprocessing concept. During the course of designing the microfluidic device, several key considerations must be taken into account: ability to withstand high pressure without leakage; materials of construction to be inert and transparent; size constraints of inlet and outlet piping; ability to accurately 3D-print the device.
Industrial Consultation
A major part of our project involved engaging with key industrial experts to better understand their wants and needs. We identified the pigment manufacturing and waste water disposal sectors as the two major players who would benefit from our work. By meeting with these leading corporations we have been able to tune our research towards the assenbly of a process that would be most attractive for industry to utilise.
Meeting with ETAD - Ecological and Toxicological Association of Dye and Pigment Manufacturers
ETAD - an association based in Basel represents over 35 different pigment and dyeing corporations internationally, coordinating a group initiative to limit adverse effects on health and the environment by their industry.Present at the meeting were Walter Hoffman – Director of ETAD, Dr Stefan Ehrenberg - Pigment Manufacturing R&D at Bezema, Georg Roentgen – Director of R&D Colours and Textile Effects at Huntsman.
The main reasons for this meeting were:
Dye Houses vs Dye Synthesis Waste
The meeting with ETAD raised a number of points for our project. Mr Roentgen questioned how the survival of our bacterial cell would be effected in dyehouse waste as opposed to dye synthesis plant waste. The waste from a dyehouse is a complex mix of azo dyes at approximately 1%-5% concentration in a high salt concentration with the presence of metals copper and chromium. This a harsh environment compared with the waste of a dye synthesis plant, generally containing one or two azo dyes in a simple mixture at 10% concentration.
This is new information for our project and has greatly influenced us to direct our research towards optimising remediation of dye synthesis waste water. Another advantage of remediation of dye synthesis plant waste water is that the low variety of azo dyes in each batch mixture will make filtration of valuable products a much easier and viable process, enhancing the economic feasibility of our device.
Sulphonated Azo Dyes
The current trend in the textile industry is to reduce the volume of water consumed, leading to a greater use of more soluble dyes. For a dye to be more soluble it must be more polar, as such, many of these soluble dyes have sulfonated groups. The sulphur atom has a electron withdrawing effect making reduction of the azo bond difficult, the industry are finding chemical processes to degrade these dyes to be ineffective.
We feel we can offer an alternative since ..lignin peroxidase…. change this is known to be effective working on azo bonds with sulphur group.
Conclusions
Overall the meeting was a great success in guiding our project towards an industrial relevant direction. Running through our presentation highlighted a number of changes needed before the jamboree, specifically putting more emphasis on the novelty and innovation of our project. Ensuring our project delivers a solution that is conscious of the needs of the industry is extremely important to us, meetings such as these are invaluable to the progression of our work.